NASDAQ:STSS Sharps Technology (STSS) Stock Price, News & Analysis $0.29 -0.01 (-3.34%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.27▼$0.3350-Day Range$0.19▼$0.5252-Week Range$0.17▼$0.90Volume4.30 million shsAverage Volume5.71 million shsMarket Capitalization$4.54 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Sharps Technology alerts: Email Address Ad WealthPressNew trading system called MSFT, NVDA & MSFTLook 2023 kind of sucked from a trading standpoint… Despite the market finishing 24% higher…. Just seven stocks did all of the work… Unless you were holding or actively trading those 7 stocks, your trading year probably wasn’t as fruitful as you had hoped… According to my research, my new trading system would have spotted all seven of the “Magnificent stocks” MONTHS before they reached the highs they are trading at today.Just follow this link here! About Sharps Technology Stock (NASDAQ:STSS)Sharps Technology, Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc. was incorporated in 2017 and is based in Melville, New York.Read More STSS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart STSS Stock News HeadlinesJuly 23 at 5:12 PM | tmcnet.comSharp Launches New M Series Standard Laser ProjectorsJuly 17, 2024 | americanbankingnews.comSharps Technology (STSS) & Its Competitors Critical ComparisonJuly 26, 2024 | WealthPress (Ad)This TSLA short trade is on a nine win hot streakMost Tesla Shareholders are disappointed in the stock's performance in 2024. Year to date, it's down 30%... And things don’t seem to be getting better. That said, one professional trader has found a way to turn Tesla’s demise into a flurry of opportunity… In fact, he has not lost a single trade on Tesla this year. As of this mailing he’s 9 for 9 with incredible wins under his belt. Just see for yourself.July 9, 2024 | globenewswire.comSharps Technology CEO Urges Shareholders to Vote in Support of the Three Proposals by the July 12 Voting DeadlineJuly 5, 2024 | benzinga.comWhat's Going On With Nano-Cap Medical Device-Focused Sharps Technology On Friday?July 3, 2024 | globenewswire.comSharps Technology Receives Purchase Orders for 1 Million SecureGard Syringes for 2024 DeliveryJuly 3, 2024 | globenewswire.comSharps Technology Urges Shareholders to Approve the Proposals in connection with the Special Meeting on July 15, 2024June 17, 2024 | globenewswire.comSharps Technology Ships First Orders for Securegard Disposable Smart Safety Syringes to Strategic Distribution Partner in ColombiaJuly 26, 2024 | DTI (Ad)We’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! June 14, 2024 | globenewswire.comJoin Sharps Technology's Exclusive Live Investor Webinar and Q&A Session on June 18June 13, 2024 | investorplace.comWhy Is Sharps Technology (STSS) Stock Up 21% Today?June 13, 2024 | globenewswire.comSharps Technology Receives $30 Million Purchase Order for Prefillable Copolymer Syringes to be Manufactured at SC FacilityMay 31, 2024 | globenewswire.comSharps Technology's SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.May 30, 2024 | globenewswire.comSharps Technology Signs 5-Year, $200 Million Syringe Sales Agreement and Amendment to Asset Purchase Agreement to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.May 28, 2024 | benzinga.comLatest News for Sharps Technology Stock (NASDAQ:STSS)May 28, 2024 | globenewswire.comSharps Technology Positioned to Address Supply Chain Disruptions Resulting from Recent FDA Recalls, Warnings, and Tariffs on Chinese Manufactured SyringesMay 28, 2024 | benzinga.comUS Stocks Mixed; Home Prices Increase In MarchMay 28, 2024 | investorplace.comWhy Is Sharps Technology (STSS) Stock Up 194% Today?See More Headlines Receive STSS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sharps Technology and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:STSS CUSIPN/A CIK1737995 Websharpstechnology.com Phone631-574-4436FaxN/AEmployees3Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-9,840,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-102.25% Return on Assets-72.97% Debt Debt-to-Equity RatioN/A Current Ratio1.15 Quick Ratio0.49 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.52 per share Price / Book0.56Miscellaneous Outstanding Shares15,670,000Free Float13,696,000Market Cap$4.54 million OptionableNot Optionable Beta1.24 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for August 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Robert M. Hayes (Age 56)CEO & Director Comp: $516.67kMr. Andrew R. Crescenzo CPA (Age 68)Chief Financial Officer Comp: $236.23kMr. Ben ScheuSenior Director of SalesDr. Steven Hertz M.D. (Age 62)Chief Medical Officer Mr. Adam S. HoldsworthManaging DirectorKey CompetitorsSonendoNYSE:SONXSintx TechnologiesNASDAQ:SINTHelius Medical TechnologiesNASDAQ:HSDTNuwellisNASDAQ:NUWEBone BiologicsNASDAQ:BBLGView All CompetitorsInsidersRobert Michael HayesBought 10,000 shares on 2/20/2024Total: $3,400.00 ($0.34/share)Timothy James RuemlerBought 4,466 shares on 1/2/2024Total: $1,786.40 ($0.40/share)Andrew R CrescenzoBought 3,500 shares on 12/28/2023Total: $1,470.00 ($0.42/share)Timothy James RuemlerBought 10,000 shares on 12/22/2023Total: $4,000.00 ($0.40/share)Timothy James RuemlerBought 10,000 shares on 11/22/2023Total: $4,500.00 ($0.45/share)View All Insider Transactions STSS Stock Analysis - Frequently Asked Questions How have STSS shares performed this year? Sharps Technology's stock was trading at $0.4159 at the beginning of 2024. Since then, STSS shares have decreased by 30.4% and is now trading at $0.2896. View the best growth stocks for 2024 here. How were Sharps Technology's earnings last quarter? Sharps Technology, Inc. (NASDAQ:STSS) released its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.05) earnings per share (EPS) for the quarter. When did Sharps Technology IPO? Sharps Technology (STSS) raised $16 million in an IPO on Thursday, April 14th 2022. The company issued 3,750,000 shares at a price of $4.25 per share. How do I buy shares of Sharps Technology? Shares of STSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:STSS) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sharps Technology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sharps Technology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.